X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (118) 118
Patent (13) 13
Book / eBook (8) 8
Newspaper Article (7) 7
Conference Proceeding (6) 6
Publication (6) 6
Book Review (3) 3
Book Chapter (2) 2
Dissertation (2) 2
Magazine Article (1) 1
Streaming Video (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (52) 52
humans (39) 39
female (27) 27
male (26) 26
aged (18) 18
adult (17) 17
middle aged (16) 16
neurosciences (15) 15
alzheimer's disease (10) 10
animals (10) 10
chemistry (10) 10
metallurgy (10) 10
physics (9) 9
alzheimers-disease (8) 8
analysis (8) 8
brain (8) 8
clinical neurology (8) 8
italy (8) 8
care and treatment (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
measuring (7) 7
organic chemistry (7) 7
peptides (7) 7
research (7) 7
testing (7) 7
aged, 80 and over (6) 6
immunotherapy (6) 6
studies (6) 6
time factors (6) 6
a-beta (5) 5
abridged index medicus (5) 5
adolescent (5) 5
amyloid-related imaging abnormalities (5) 5
disease (5) 5
graphene (5) 5
inflammation (5) 5
magnetic resonance imaging (5) 5
management (5) 5
multidisciplinary sciences (5) 5
neurology (5) 5
oncology (5) 5
patients (5) 5
science (5) 5
surgery (5) 5
transplantation (5) 5
treatment outcome (5) 5
usage (5) 5
amyloid beta-peptides - immunology (4) 4
bace1 (4) 4
blood (4) 4
cardiac & cardiovascular systems (4) 4
cerebral amyloid angiopathy - complications (4) 4
clinical trials (4) 4
complications and side effects (4) 4
diagnosis (4) 4
drug administration schedule (4) 4
imaging abnormalities (4) 4
immunology (4) 4
intervention (4) 4
materials science, multidisciplinary (4) 4
medicine (4) 4
mental disorders (4) 4
mice (4) 4
mortality (4) 4
mutation (4) 4
physics, applied (4) 4
risk factors (4) 4
therapy (4) 4
activation (3) 3
allergy (3) 3
alzheimer disease - blood (3) 3
alzheimer disease - immunology (3) 3
amyloid precursor protein (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
apparatus therefor (3) 3
atomic force microscopy (3) 3
autoantibodies - cerebrospinal fluid (3) 3
bapineuzumab (3) 3
biology (3) 3
cancer (3) 3
case-control studies (3) 3
cell biology (3) 3
cerebral amyloid angiopathy (3) 3
cerebral amyloid angiopathy related inflammation (3) 3
chemical treatment of hides, skins or leather, e.g. tanning,impregnating, finishing (3) 3
chemistry, physical (3) 3
child (3) 3
compositions for tanning (3) 3
disorders (3) 3
economic models (3) 3
follow-up studies (3) 3
gene (3) 3
gene expression (3) 3
graphen (3) 3
hematology (3) 3
hemorrhage (3) 3
hides (3) 3
icaβ international network (3) 3
impact (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 01/2018, Volume 90, Issue 3, pp. 144 - 145
Journal Article
Journal of Management, ISSN 0149-2063, 1/2014, Volume 40, Issue 1, pp. 287 - 315
Status is a pervasive construct in the organizational literature, and a recent surge in interest in the topic testifies to its potential as a field of study.... 
rank | social evaluations | hierarchies | prestige | status | REPUTATION | MANAGEMENT | STATUS-INCONSISTENCY | MOBILITY | PERFORMANCE | PSYCHOLOGY, APPLIED | POWER | BUSINESS | MARKET ENTRY | CONSTRUCTION | STRUCTURAL HOLES | SOCIAL-STATUS | EXCHANGE | Employee morale | Research | Work design | Work environment | Studies | Status | Management theory | Hierarchies | Corporate management
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 05/2016, Volume 52, Issue 2, pp. 417 - 420
Journal Article
Organization Science, ISSN 1047-7039, 6/2015, Volume 26, Issue 3, pp. 724 - 742
How do organizations react to stakeholder disapproval of a category to which they belong? In this paper, we draw on the categorization, stigma, and identity... 
stigma | categories | identity | firm behavior | nuclear power | Nuclear power | Identity | Categories | Stigma | Firm behavior | ATTENTION | ORGANIZATIONAL LEGITIMACY | MARKET | MANAGEMENT | CONSTRUCTIONIST APPROACH | INDUSTRY | POLITICS | MASS-MEDIA | PUBLIC-OPINION | IMPRESSION MANAGEMENT | Environmental aspects | Nuclear industry | Nuclear energy | Electric power production | Studies | Electricity generation | Nuclear power plants
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 01/2015, Volume 45, Issue 2, pp. 363 - 367
Cerebral amyloid angiopathy-related inflammation (CAA-ri), a rare form of vasculitis associated with amyloid- (A) deposition in vessel walls, has been proposed... 
Journal Article
Annals of Neurology, ISSN 0364-5134, 04/2013, Volume 73, Issue 4, pp. 449 - 458
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2011, Volume 103, Issue 7, pp. 553 - 561
Background Imatinib slows development of chronic myeloid leukemia (CML). However, available information on morbidity and mortality is largely based on... 
CHRONIC MYELOGENOUS LEUKEMIA | MESYLATE | RESPONSES | INTERFERON | THERAPY | ONCOLOGY | RESISTANCE | FOLLOW-UP | PATIENTS RECEIVING IMATINIB | POSITIVE LEUKEMIAS | TRANSPLANTATION | Piperazines - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Time Factors | Antineoplastic Agents - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Polymerase Chain Reaction | Adult | Female | Odds Ratio | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Drug Administration Schedule | Pyrimidines - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Remission Induction | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Benzamides | Development and progression | Care and treatment | Chronic myeloid leukemia | Research | Drug therapy | Patient outcomes | Cytogenetics | Side effects | Leukemia | Mortality | Edema | Imatinib | Statistical analysis | Sex | Clinical trials | Diarrhea | Muscles | Survival | Morbidity | Hemopoiesis | Philadelphia chromosome | Tendons | Polymerase chain reaction | Asthenia | Remission | Ligaments | Index Medicus
Journal Article
Annals of Neurology, ISSN 0364-5134, 04/2013, Volume 73, Issue 4, pp. 449 - 458
  Objective Cerebral amyloid angiopathy-related inflammation (CAA-ri) is characterized by vasogenic edema and multiple cortical/subcortical microbleeds,... 
Medical research | Beta
Journal Article
Beilstein Journal of Nanotechnology, ISSN 2190-4286, 2017, Volume 8, Issue 1, pp. 254 - 263
Molybdenum disulphide (MoS2) is currently regarded as a promising material for the next generation of electronic and optoelectronic devices. However, several... 
MoS | Mobility | Temperature dependence | Contact resistance | Threshold voltage | DENSITY | mobility | PHYSICS, APPLIED | contact resistance | MoS2 | threshold voltage | HYSTERESIS | MATERIALS SCIENCE, MULTIDISCIPLINARY | temperature dependence | NANOSCIENCE & NANOTECHNOLOGY | METAL | FIELD-EFFECT TRANSISTORS | Field effect transistors
Journal Article
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, ISSN 0027-8424, 03/2019, Volume 116, Issue 10, pp. 4625 - 4630
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 797 - 18
Journal Article
Beilstein Journal of Nanotechnology, ISSN 2190-4286, 2017, Volume 8, Issue 1, pp. 418 - 424
The effects of temperature and atmosphere (air and O2) on the doping of monolayers of graphene (Gr) on SiO2 and Si substrates, and on the doping of MoS2... 
MoS | Thermal doping | Raman spectroscopy | Graphene | Two-dimensional (2D) materials | thermal doping | two-dimensional (2D) materials | MoS2 | graphene
Journal Article
physica status solidi (a), ISSN 1862-6300, 09/2016, Volume 213, Issue 9, pp. 2341 - 2344
Stability in ambient air or in vacuum-controlled atmosphere of molecular oxygen-induced p-type doping of graphene monolayer on SiO2 substrate on Si is... 
AFM | SiO | graphene doping | Raman |